Create a narrative

ANGLE Community

AIM:AGL Community

1 Narratives written by author
0 Comments on narratives written by author
3 Fair Values set on narratives written by author

Create a narrative

AN

AnalystConsensusTarget

AnalystConsensusTarget

Consensus Narrative from 3 Analysts

Pharma Partnerships And Liquid Biopsy Will Expand Future Markets

Key Takeaways ANGLE's unique technologies and partnerships in precision oncology position it for strong, margin-expanding revenue growth as liquid biopsy adoption accelerates. Ongoing innovation, clinical validation, and disciplined cost management enhance ANGLE's competitive strength, diversify revenues, and improve long-term profitability.

UK£0.28

FV

79.5% undervalued

138.15%

Revenue growth p.a.

1

0

3

14 days ago